Daily Editions
Contents
  1. Page 1: Today’s IndexTLDR · 9 stories
  2. Page 2: TLDRTLDR · 4 stories
  3. Page 3: Resources & ToolsTLDR · 2 stories
?
Keyboard shortcuts
← / →
Previous / next page
↑ / ↓
Scroll while full screen
PgUp / PgDn
Scroll by viewport
Space
Scroll down by viewport
Shift+Space
Scroll up by viewport
Home
First page
End
Last page
F
Full screen
Escape
Exit immersive mode

Daily Edition · Page 1

THE DAILY INDEX

Technology, AI, software, security, crypto and business

Across today’s newsletters

Today’s Index

TESLA GIGA SHANGHAI TO RELEASE 2024 MODEL Y REFRESH AS COMPETITION HEATS UP IN CHINA

Tesla is already preparing to produce the 2024 refresh Model Y at Gigafactory Shanghai, with mass production expected to start by mid-2024. The refresh will have significant changes compared to the updated units released in October 2023. The new Model Y will have more noticeable changes to the exterior and interior to compete with new electric car units to be released in China next year. It is expected to feature a new wheel design with ambient lighting.

4-YEAR CAMPAIGN BACKDOORED IPHONES USING POSSIBLY THE MOST ADVANCED EXPLOIT EVER

Researchers have discovered an attack that backdoored possibly thousands of iPhones over four years. Many of the affected phones belonged to Moscow-based security firm Kaspersky. The attackers were able to achieve an unprecedented level of access by exploiting a vulnerability in an undocumented hardware feature that few people know of. It is still unknown how they became aware of the feature. The exploit was delivered through iMessage texts which installed malware without requiring the receiver to take any action. Apple has patched the exploit, which also affected Macs, iPods, iPads, Apple TVs, and Apple Watches.

INJECTION OF “SMART INSULIN” REGULATES BLOOD GLUCOSE LEVELS FOR ONE WEEK

Glucose-responsive insulin, or 'smart' insulin, is a form of insulin that provides control of blood glucose levels over a longer period of time than normal insulin. A recent study reported that a single injection of a smart insulin system was able to regulate blood glucose levels in diabetic mice and minipigs for a week. The system mimics the body's natural process, releasing insulin in response to glucose. Research into smart insulin is still in its early stages, but the study demonstrated that it could be a viable research subject heading forward.

FONTIMIZE

Fontimize is a Python library for subsetting fonts. It can cut the size of font files by around 95%, resulting in saved bandwidth. Fontimize's Magic Method generates new versions of fonts with only the glyphs needed to render the specific website. It features a flexible API and command-line utility that allows users to customize output locations, use specific font files, change verbosity, return information about what characters were found and what fonts were generated, and more.

MY CCPA DIALOG WITH OPENAI

This article contains an exchange with OpenAI following the filing of a CCPA request. The aim of the filing was to see how large language models might comply with privacy regulations like the CCPA and GDPR when it comes to their training data sets. While OpenAI never really settled the original CCPA request, the exchange illuminated its approach to privacy and training data. It appears OpenAI is currently using the hallucination excuse to handle privacy requests, and while they are releasing products at a truly impressive pace, it doesn't seem that legal and support are keeping up.

BIG TECH IS SPENDING MORE THAN VC FIRMS ON AI STARTUPS

Big Tech companies have vastly outspent venture capital firms with generative AI startup investments this year. Microsoft, Google, and Amazon are responsible for two-thirds of the $27 billion raised by AI startups in 2023. Building and training generative AI tools is expensive and requires immense computing power, so startups have preferred to partner with Big Tech companies that can provide infrastructure and funds. This has rapidly pushed up the valuations of private startups, making it harder for VCs to invest in the most cutting-edge companies.

TLDR IndexPage 1